CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 114 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 3.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $17,000 | -46.9% | 3,390 | +34.4% | 0.00% | – |
| Q4 2020 | $32,000 | +28.0% | 2,522 | 0.0% | 0.00% | – |
| Q3 2020 | $25,000 | -30.6% | 2,522 | -30.5% | 0.00% | – |
| Q2 2020 | $36,000 | +24.1% | 3,631 | +10.1% | 0.00% | – |
| Q1 2020 | $29,000 | -12.1% | 3,299 | -6.7% | 0.00% | – |
| Q4 2019 | $33,000 | +57.1% | 3,535 | 0.0% | 0.00% | – |
| Q3 2019 | $21,000 | -50.0% | 3,535 | 0.0% | 0.00% | – |
| Q2 2019 | $42,000 | -2.3% | 3,535 | 0.0% | 0.00% | – |
| Q1 2019 | $43,000 | +7.5% | 3,535 | +11.3% | 0.00% | – |
| Q4 2018 | $40,000 | -14.9% | 3,177 | 0.0% | 0.00% | – |
| Q3 2018 | $47,000 | -11.3% | 3,177 | 0.0% | 0.00% | – |
| Q2 2018 | $53,000 | -27.4% | 3,177 | +0.2% | 0.00% | – |
| Q1 2018 | $73,000 | -38.1% | 3,172 | -30.3% | 0.00% | – |
| Q4 2017 | $118,000 | +49.4% | 4,552 | -15.9% | 0.00% | – |
| Q3 2017 | $79,000 | +27.4% | 5,414 | +22.2% | 0.00% | – |
| Q2 2017 | $62,000 | -16.2% | 4,429 | 0.0% | 0.00% | – |
| Q1 2017 | $74,000 | +39.6% | 4,429 | -14.3% | 0.00% | – |
| Q4 2016 | $53,000 | +152.4% | 5,168 | +142.1% | 0.00% | – |
| Q3 2016 | $21,000 | -12.5% | 2,135 | 0.0% | 0.00% | – |
| Q2 2016 | $24,000 | -17.2% | 2,135 | 0.0% | 0.00% | – |
| Q1 2016 | $29,000 | – | 2,135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 968,198 | $9,634,000 | 3.29% |
| INGALLS & SNYDER LLC | 1,382,048 | $13,751,000 | 0.79% |
| SPHERA FUNDS MANAGEMENT LTD. | 700,710 | $6,972,000 | 0.66% |
| Alambic Investment Management, L.P. | 17,900 | $178,000 | 0.45% |
| RA Capital Management | 1,858,474 | $18,492,000 | 0.36% |
| Perceptive Advisors | 2,150,641 | $21,398,000 | 0.35% |
| Eversept Partners, LP | 232,983 | $2,318,181 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 17,351 | $173,000 | 0.10% |
| Alyeska Investment Group, L.P. | 502,783 | $5,003,000 | 0.08% |
| KENNEDY CAPITAL MANAGEMENT LLC | 263,958 | $2,626,000 | 0.08% |